Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
The key question on the Clinton Foundation is whether it saved lives. The answer is clearly yes

After reviewing foundation documents and talking to numerous people in the philanthropy and global health sectors familiar with its work, I’ve come to the conclusion that the Clinton Foundation is a real charitable enterprise that did enormous good. Its projects are of varying effectiveness, but its work is supported by credible, discriminating funders, and the foundation has least one huge accomplishment under its belt — an HIV/AIDS program that saved an untold number of lives.

Published
27 September 2016
From
Vox
Behind Battle Over Drug Prices, Quiet Money From Big Pharma

Is there a conflict of interest for hepatitis C advocates in accepting funds from pharmaceutical companies and representing the interests of patients when questions of drug pricing and access to treatment are being debated?

Published
19 September 2016
From
Bloomberg
NHS funding cuts ‘forcing people to buy medicine through Facebook’

Patients and researchers say the medicine is safe, however pharmacists have warned that medicine bought online could be placebo pills or contain dangerous ingredients.

Published
16 September 2016
From
The Independent
Delays in updating HIV treatment guidelines in Africa blocking early treatment for millions

Delays in adopting the World Health Organization (WHO) 2015 recommendation of HIV treatment for all threaten the achievement of the 90-90-90 targets for HIV diagnosis and viral

Published
12 September 2016
By
Keith Alcorn
Why 2.1 million Indians infected with HIV do not get the drugs they need

Each of an estimated 2.1 million Indians infected with the human immunodeficiency virus (HIV) should be getting a cocktail of drugs to prolong their lives and reduce infections, but no more than 44% do, the minister of health told the Lok Sabha (parliament’s lower house) in April 2016.

Published
12 September 2016
From
Firstpost
Matthias Wienold – Going shopping for PrEP in Germany

Matthias Wienold, a German physician who uses PrEP, describes the situation where he can use his doctor's licence to buy PrEP abroad - but has to conceal to his home authorities that it is for personal use.

Published
09 September 2016
From
EATG
Letter to Gilead Sciences on attempts to remove generic sofosbuvir from Ukraine

MSF is in the process of planning and beginning to deliver hepatitis C treatment to patients in Ukraine, a country suffering from the highest hepatitis C prevalence in the region - and which has one of the world’s highest rates of hepatitis C infection. The availability of multiple sources of new DAAs - and, in particular, sofosbuvir - is critical for treatment providers, including MSF, to manage a sustainable and affordable supply for medical operations.

Published
07 September 2016
From
MSF
Atlanta group joins federal complaint against HIV drug costs

An Atlanta AIDS group joined a multi-state effort Tuesday to reduce the costs of HIV drugs by two insurance firms, asserting that the high prices discriminate against people living with the disease.

Published
07 September 2016
From
Atlanta Journal Constitution
Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

The latest battle over access to medicines is taking place in Ukraine, where Doctors Without Borders is urging Gilead Sciences to drop a court action that, if successful, would prevent a generic version of the Sovaldi hepatitis C treatment from ...

Published
07 September 2016
From
STAT
Ukraine's medicine bill slashed by 25% after UK firm brought in to handle procurement

Crown Agents and two UN agencies are working to root out corrupt intermediaries but are facing politcal resistance to change.

Published
01 September 2016
From
The Guardian
← First12345...115Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close